Logo
  • Home
  • AI Agent
  • Annotations
  • Files
  • Pricing and plans
  • BlogAboutContact us
    APIMCP
    Terms of servicePrivacy policy
  • Get the full experience

    We save the real magic for signed-in users.

HIMS US​
HomeStock ScreenerDocument SearchChartingWatchlistsRecent Filings

Hims & Hers Health, Inc.(HIMS US)

$19.87+0.140.68%(Market Open · 18:43:09 UTC)
Ask AI
Doc SearchProfileEntity StructureFinancialsChartingShort InterestEmployees

Overview

ProfileEntity Structure

Documents

SEC Filings
Logo
  • Home
  • AI Agent
  • Annotations
  • Files
  • Pricing and plans
  • BlogAboutContact us
    APIMCP
    Terms of servicePrivacy policy
  • Get the full experience

    We save the real magic for signed-in users.

HIMS US​
HomeStock ScreenerDocument SearchChartingWatchlistsRecent Filings

Hims & Hers Health, Inc.(HIMS US)

$19.87+0.140.68%(Market Open · 18:43:09 UTC)
Ask AI
Doc SearchProfileEntity StructureFinancialsChartingShort InterestEmployees

Overview

ProfileEntity Structure

Documents

SEC Filings

Financials & Metrics

FinancialsChartingShort InterestEmployees

Financials & Metrics

FinancialsChartingShort InterestEmployees

Hims & Hers Health, Inc. — Company Profile

Hims & Hers Health, Inc. operates a comprehensive digital health platform that seamlessly links individuals with licensed medical professionals for virtual consultations and ongoing care. Through its user-friendly websites and mobile app, the company delivers a diverse portfolio of health and wellness solutions directly to consumers. This includes access to recurring prescription medications, alongside a wide selection of over-the-counter drugs, devices, cosmetics, and dietary supplements. Its core focus areas are general wellness, sexual health, skincare, and hair care. Specific non-prescription offerings span categories such as: Wellness: encompassing items like vitamin C, melatonin, biotin, and collagen protein supplements. Skincare: including products such as moisturizers, serums, and face washes. Sexual Health: providing essentials like condoms, climax delay sprays and wipes, vibrators, and lubricants. Hair Care: offering specialized shampoos, conditioners, scalp scrubs, and topical treatments like minoxidil. Beyond direct sales, Hims & Hers also distributes health and wellness products via wholesale partnerships. The company's headquarters are located in San Francisco, California.

Sector
Consumer Staples
Industry
Personal Care Products
Exchange
UN
CEO
Andrew Dudum
Headquarters
San Francisco, CA, US
IPO Date
Sep 13, 2019
Employees
2,442
Website
www.hims.com

Key Metrics

Price
$29.00
Market Cap
$6.47B
Revenue (TTM)
$608.10M
Net Income (TTM)
$-92115000.00
EPS (TTM)
-0.40
P/E (TTM)
-488.80
P/B (TTM)
14.50
Dividend Yield
0.00%
ROE (TTM)
-20.65%
ROA (TTM)
-4.06%
Operating Margin
-2.71%
Beta
2.53

Dividends

Last Dividend
$0.00
Last Yield
0.00%

Summary

Hims & Hers Health, Inc. operates a comprehensive digital health platform that seamlessly links individuals with licensed medical professionals for virtual consultations and ongoing care. Through its user-friendly websites and mobile app, the company delivers a diverse portfolio of health and wellness solutions directly to consumers. This includes access to recurring prescription medications, alongside a wide selection of over-the-counter drugs, devices, cosmetics, and dietary supplements. Its core focus areas are general wellness, sexual health, skincare, and hair care. Specific non-prescription offerings span categories such as: Wellness: encompassing items like vitamin C, melatonin, biotin, and collagen protein supplements. Skincare: including products such as moisturizers, serums, and face washes. Sexual Health: providing essentials like condoms, climax delay sprays and wipes, vibrators, and lubricants. Hair Care: offering specialized shampoos, conditioners, scalp scrubs, and topical treatments like minoxidil. Beyond direct sales, Hims & Hers also distributes health and wellness products via wholesale partnerships. The company's headquarters are located in San Francisco, California.

Website
www.hims.com
Location
San Francisco, CA, US
Phone415 851 0195
Employees2,442
CEOAndrew Dudum
Sector
Consumer Staples
Industry
Personal Care Products
IPO DateSep 13, 2019

Ask AI

Company overview
Business model, segments, and competition.
Peer comparison
Metrics vs closest competitors.
Guidance & outlook
Forward guidance and assumptions.
Bull vs bear case
Upside drivers and key risks.
Valuation snapshot
Multiples vs history and peers.
Competitive moat
Defensibility and market position.
Management track record
Leadership and capital allocation history.
How it makes money
A short diagram of the business model.

Latest Documents

SEC Filings(1.3K)

Expand
  • Form 4Payne Christopher D04:17PM
  • Form 4Franklin Jonathan M04:17PM
  • Form 4WELLS DAVID B04:17PM
  • Form 4Huberman Andrew D04:17PM
  • Form 3Huberman Andrew D12 Nov
  • 10-QQ3ended 30 Sept 20269 Nov
  • 8-KDeparture of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers9 Nov
  • 8-KResults of Operations and Financial Condition9 Nov
  • SC 13G/AHims & Hers Health, Inc.30 Oct
  • Form 4Boughton Soleil29 Oct
  • Form 144Boughton Soleil28 Oct
  • Form 4Boughton Soleil15 Oct
  • Form 3Franklin Jonathan M15 Oct
  • Form 144Boughton Soleil14 Oct
  • 8-KDeparture of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers7 Oct
  • Form 4Okupe Oluyemi2 Oct
  • Form 4Boughton Soleil2 Oct
  • Form 144Okupe Oluyemi1 Oct
  • Form 144Boughton Soleil30 Sep
  • Form 4Okupe Oluyemi23 Sep

News

  • Hims & Hers Stock Just Plummeted 17%. Is the Stock a Buy Ahead of a Peptide Push?12:40PM
  • HIMS Partners With Lilly to Offer FDA-Approved Weight-Loss Drugs12:16PM
  • Hims & Hers Health, Inc. (HIMS) Is a Trending Stock: Facts to Know Before Betting on It10:01AM
  • Hims & Hers Bounced Back 9%, But Its Earnings Reveal a Costly Trade-Off12 Nov
  • Hims & Hers: Three Big Sacrifices11 Nov
  • Hims & Hers Q3 Earnings Miss Estimates, Gross Margin Down11 Nov
  • Hims & Hers Health: The Thesis Is Getting Shaky (Rating Downgrade)11 Nov
  • Hims & Hers Climbs 6% Despite Five States Joining FTC Suit; Eli Lilly Dips, Novo Nordisk Holds Steady11 Nov
  • Hims & Hers Week in Review: Q3 Miss, Weak Q4 Outlook, Huberman Joins Board11 Nov
  • A $400 Billion Healthcare Opportunity: Telehealth Companies Positioned to Capitalize on a Massive Industry Shift11 Nov
  • HIMS Q3 Earnings Call Highlights Marketing Reset and Margin Pressure10 Nov
  • Hims & Hers Health: Don't Nitpick Quarterly Results10 Nov
  • Weight-Loss Reset Dents Hims & Hers Outlook, But Analyst Sees Opportunity10 Nov
  • Hims & Hers Drops 18% as Q3 Loss and Profit Outlook Cut Disappoint; Novo Nordisk Slides 2%, Eli Lilly Holds Steady10 Nov
  • 4 Post-Earnings Losers Drawing Unusual Options Volume10 Nov
  • Hims & Hers Celebrated Its Eli Lilly Deal, Then Lost a Quarter of Its Value in a Week10 Nov
  • HIMS Earnings Stumble on Double Miss, Guidance Becomes New Focus10 Nov
  • Hims & Hers: Why I'm Not Buying Back Yet (Rating Downgrade)10 Nov
  • Hims & Hers Stock Feels a Pinch Tuesday: What's Happening?10 Nov
  • Hims & Hers Just Warned Investors for the Third Time This Year. CEO Andrew Dudum Calls the Subscriber Losses a Trade He'll Make ‘Every Time'10 Nov

Mentions in Filings

  • … ecutive, particularly at technology companies. Other Public Company Boards: Mr. Amoo-Gottfried has served as a director of Vital Farms, Inc., a company that offers a range of ethically produced foods, since January 2021, and as a director of <strong>Hims & Hers Health, Inc.</strong>, a modern health and wellness company, since June 2026. Private Company / Non-Profit Boards: Mr. Amoo-Gottfried has served on the Board of Trustees of Macalester College since 2021.
    Stitch Fix, Inc.Hims & Hers Health, Inc.·DEF 14A - Definitive proxy statement·Q1 27·3 Nov
  • … this Summary Prospectus. **GraniteShares YIELDBOOST HIMS ETF – Summary** **Investment Objective** The Fund’s primary investment objective is to achieve 2 times (200%) the income generated from selling options on <strong>Hims & Hers Health</strong>, Inc.’s common stock (NYSE: HIMS) (the “Underlying Stock”) by selling options on leveraged exchange-traded funds designed to deliver 2 times (200%) the daily performance of the Underlying Stock (the “Underlying Leve …
    GraniteShares ETF TrustHims & Hers Health, Inc.·497K - Form 497K - Summary prospectus·28 Oct·28 Oct
  • … and wellness needs. Its platform includes access to a provider network, a clinically focused electronic medical record system, digital prescriptions, cloud pharmacy fulfillment, and personalization capabilities. <strong>Hims & Hers Health, Inc.</strong> is registered under the Securities Exchange Act of 1934, as amended (the “Exchange Act”). Information provided to or filed with the Securities and Exchange Commission by Hims & Hers Health, Inc. pursuant to the E …
    GraniteShares ETF TrustHims & Hers Health, Inc.·497 - Form 497 - Definitive materials (investment companies)·28 Oct·28 Oct
  • … 4,204 | 29.30 | 1,588,177.20 | | | | SPROUTS FARMERS MARKET INC | 24,277 | 82.68 | 2,007,222.36 | | | | TARGET CORP | 14,093 | 155.51 | 2,191,602.43 | | | | HCA HEALTHCARE INC | 4,471 | 411.74 | 1,840,889.54 | | | | <strong>HIMS & HERS HEALTH</strong> INC | 145,619 | 28.77 | 4,189,458.63 | | | | UNITEDHEALTH GROUP INC | 7,209 | 399.06 | 2,876,823.54 | | | | ELI LILLY & CO | 1,498 | 1,209.00 | 1,811,082.00 | | | | PFIZER INC | 111,105 | 26.80 | 2,977,614.00 | | | …
    三菱UFJアセットマネジメント株式会社Hims & Hers Health, Inc.·Annual Report - Annual Securities Report (2025.08.15-2026.08.14)·13 Nov·12 Nov
  • … 4,204 | 29.30 | 1,588,177.20 | | | | SPROUTS FARMERS MARKET INC | 24,277 | 82.68 | 2,007,222.36 | | | | TARGET CORP | 14,093 | 155.51 | 2,191,602.43 | | | | HCA HEALTHCARE INC | 4,471 | 411.74 | 1,840,889.54 | | | | <strong>HIMS & HERS HEALTH</strong> INC | 145,619 | 28.77 | 4,189,458.63 | | | | UNITEDHEALTH GROUP INC | 7,209 | 399.06 | 2,876,823.54 | | | | ELI LILLY & CO | 1,498 | 1,209.00 | 1,811,082.00 | | | | PFIZER INC | 111,105 | 26.80 | 2,977,614.00 | | | …
    三菱UFJアセットマネジメント株式会社Hims & Hers Health, Inc.·Prospectus - Securities registration statement·13 Nov·12 Nov
  • … 4,204 | 29.30 | 1,588,177.20 | | | | SPROUTS FARMERS MARKET INC | 24,277 | 82.68 | 2,007,222.36 | | | | TARGET CORP | 14,093 | 155.51 | 2,191,602.43 | | | | HCA HEALTHCARE INC | 4,471 | 411.74 | 1,840,889.54 | | | | <strong>HIMS & HERS HEALTH</strong> INC | 145,619 | 28.77 | 4,189,458.63 | | | | UNITEDHEALTH GROUP INC | 7,209 | 399.06 | 2,876,823.54 | | | | ELI LILLY & CO | 1,498 | 1,209.00 | 1,811,082.00 | | | | PFIZER INC | 111,105 | 26.80 | 2,977,614.00 | | | …
    三菱UFJアセットマネジメント株式会社Hims & Hers Health, Inc.·Prospectus - Securities registration statement·13 Nov·12 Nov

Key Stats

Trading

Px/Chg 1D$29.00 / -1.02%
Avg Volume30.89M
Beta2.53
Mkt Cap6.47B
FD Mkt Cap6.56B

Float

Shrs Out/Float223.08M / 208.82M
Short Float0.29%
Days to Cover3.23
Stock Repurchased$0.00

Current Valuation

EV7.38B
EV/EBITDA308.40
EV/Sales3.11
P/B14.50
P/S2.73
FCF Yield0.82%
ROE-20.65%
ROA-4.06%
Current Ratio1.69

Estimates

P/E-488.80
Est P/E0.00
Est EPS0.03
Est PEG0.00

Valuation

Metric5Yr AvgMay '23May '24May '25May '26Oct '26
PRICE-BASED RATIOS
Price / Earnings34.74-37.49-100.1169.94311.58-70.23
Price / Sales6.874.672.705.9710.3910.64
Price / Book Value11.927.906.8518.4911.8714.50
Price / Free Cash Flow1,592.42-72.9050.1644.447,818.38121.99
ENTERPRISE VALUE METRICS
Enterprise Value5,597.42,420.92,270.58,605.47,310.97,379.1
Enterprise Value / Sales7.404.592.605.8311.8312.13
Enterprise Value / EBITDA12.68-39.54-113.88108.94200.60-92.70
Enterprise Value / EBIT70.47-35.24-77.09139.01398.35-72.66

Financials

Full Financials
Millions USD5Yr CAGR (%)Dec '21Dec '22Dec '23Dec '24Dec '25
INCOME STATEMENT
Revenue71.4%271.9526.9872.01,476.52,347.6
Gross Income70.6%204.5408.7714.91,173.11,733.4
EBITDA—-111.0-61.2-19.979.0178.4
EBIT—-115.0-68.7-29.561.9123.9
Net Income—-107.7-65.7-23.5126.0128.4
EPS (Diluted)—-0.58-0.32-0.110.530.51
BALANCE SHEET
Cash & ST Inv23.6%247.3179.6221.0300.3577.5
Total Assets50.4%420.6366.3441.2707.52,154.7
Total Liabilities108.2%86.054.697.2230.81,613.8
Total Shareholder Equity12.8%334.6311.7344.0476.7540.9
CASH FLOW
Net Operating Cash Flow—-34.4-26.573.5251.1300.0
Cap Ex159.2%-5.0-7.2-26.5-52.8-226.0
Free Cash Flow—-39.4-33.847.0198.374.0

Enterprise Value Bridge

Millions USD13 Nov '26
Price (As of 13 Nov '26)19.74
Basic Shares223.08
Market Cap4,402.7
Diluted Shares231.75
Fully Diluted Shares Outstanding231.75
Fully Diluted Market Cap4,573.7
+Consolidated Debt1,546.2
−In-the-Money Convertible Debt—
+Capital Leases169.4
+Operating Leases—
−Cash & Equivalents-609.8
−Short-term Investments-231.2
+Total Preferred-
−In-the-Money Convertible Preferred—
−Investments in Unconsolidated Subs—
+Non-Controlling Interest-
+Pension Liabilities—
Enterprise Value5,339.1

Segment data

Revenue

by Geography

  • United States94%
  • Non-us6%

Related companies

HCA Healthcare, Inc.

HCA US

Tenet Healthcare Corp

THC US

Universal Health Services Inc

UHS US

Surgery Partners, Inc.

SGRY US

Teladoc Health, Inc.

TDOC US

Community Health Systems Inc

CYH US

Auna S.a.

AUNA US

PHYHEALTH Corp

OSCI US

Basel Medical Group Ltd

BMGL US

Rennova Health, Inc.

RNVA US

Cardiff Lexington Corp

CDIX US

Hims & Hers Health, Inc. — Company Profile

Hims & Hers Health, Inc. operates a comprehensive digital health platform that seamlessly links individuals with licensed medical professionals for virtual consultations and ongoing care. Through its user-friendly websites and mobile app, the company delivers a diverse portfolio of health and wellness solutions directly to consumers. This includes access to recurring prescription medications, alongside a wide selection of over-the-counter drugs, devices, cosmetics, and dietary supplements. Its core focus areas are general wellness, sexual health, skincare, and hair care. Specific non-prescription offerings span categories such as: Wellness: encompassing items like vitamin C, melatonin, biotin, and collagen protein supplements. Skincare: including products such as moisturizers, serums, and face washes. Sexual Health: providing essentials like condoms, climax delay sprays and wipes, vibrators, and lubricants. Hair Care: offering specialized shampoos, conditioners, scalp scrubs, and topical treatments like minoxidil. Beyond direct sales, Hims & Hers also distributes health and wellness products via wholesale partnerships. The company's headquarters are located in San Francisco, California.

Sector
Consumer Staples
Industry
Personal Care Products
Exchange
UN
CEO
Andrew Dudum
Headquarters
San Francisco, CA, US
IPO Date
Sep 13, 2019
Employees
2,442
Website
www.hims.com

Key Metrics

Price
$29.00
Market Cap
$6.47B
Revenue (TTM)
$608.10M
Net Income (TTM)
$-92115000.00
EPS (TTM)
-0.40
P/E (TTM)
-488.80
P/B (TTM)
14.50
Dividend Yield
0.00%
ROE (TTM)
-20.65%
ROA (TTM)
-4.06%
Operating Margin
-2.71%
Beta
2.53

Dividends

Last Dividend
$0.00
Last Yield
0.00%

Summary

Hims & Hers Health, Inc. operates a comprehensive digital health platform that seamlessly links individuals with licensed medical professionals for virtual consultations and ongoing care. Through its user-friendly websites and mobile app, the company delivers a diverse portfolio of health and wellness solutions directly to consumers. This includes access to recurring prescription medications, alongside a wide selection of over-the-counter drugs, devices, cosmetics, and dietary supplements. Its core focus areas are general wellness, sexual health, skincare, and hair care. Specific non-prescription offerings span categories such as: Wellness: encompassing items like vitamin C, melatonin, biotin, and collagen protein supplements. Skincare: including products such as moisturizers, serums, and face washes. Sexual Health: providing essentials like condoms, climax delay sprays and wipes, vibrators, and lubricants. Hair Care: offering specialized shampoos, conditioners, scalp scrubs, and topical treatments like minoxidil. Beyond direct sales, Hims & Hers also distributes health and wellness products via wholesale partnerships. The company's headquarters are located in San Francisco, California.

Website
www.hims.com
Location
San Francisco, CA, US
Phone415 851 0195
Employees2,442
CEOAndrew Dudum
Sector
Consumer Staples
Industry
Personal Care Products
IPO DateSep 13, 2019

Ask AI

Company overview
Business model, segments, and competition.
Peer comparison
Metrics vs closest competitors.
Guidance & outlook
Forward guidance and assumptions.
Bull vs bear case
Upside drivers and key risks.
Valuation snapshot
Multiples vs history and peers.
Competitive moat
Defensibility and market position.
Management track record
Leadership and capital allocation history.
How it makes money
A short diagram of the business model.

Latest Documents

SEC Filings(1.3K)

Expand
  • Form 4Payne Christopher D04:17PM
  • Form 4Franklin Jonathan M04:17PM
  • Form 4WELLS DAVID B04:17PM
  • Form 4Huberman Andrew D04:17PM
  • Form 3Huberman Andrew D12 Nov
  • 10-QQ3ended 30 Sept 20269 Nov
  • 8-KDeparture of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers9 Nov
  • 8-KResults of Operations and Financial Condition9 Nov
  • SC 13G/AHims & Hers Health, Inc.30 Oct
  • Form 4Boughton Soleil29 Oct
  • Form 144Boughton Soleil28 Oct
  • Form 4Boughton Soleil15 Oct
  • Form 3Franklin Jonathan M15 Oct
  • Form 144Boughton Soleil14 Oct
  • 8-KDeparture of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers7 Oct
  • Form 4Okupe Oluyemi2 Oct
  • Form 4Boughton Soleil2 Oct
  • Form 144Okupe Oluyemi1 Oct
  • Form 144Boughton Soleil30 Sep
  • Form 4Okupe Oluyemi23 Sep

News

  • Hims & Hers Stock Just Plummeted 17%. Is the Stock a Buy Ahead of a Peptide Push?12:40PM
  • HIMS Partners With Lilly to Offer FDA-Approved Weight-Loss Drugs12:16PM
  • Hims & Hers Health, Inc. (HIMS) Is a Trending Stock: Facts to Know Before Betting on It10:01AM
  • Hims & Hers Bounced Back 9%, But Its Earnings Reveal a Costly Trade-Off12 Nov
  • Hims & Hers: Three Big Sacrifices11 Nov
  • Hims & Hers Q3 Earnings Miss Estimates, Gross Margin Down11 Nov
  • Hims & Hers Health: The Thesis Is Getting Shaky (Rating Downgrade)11 Nov
  • Hims & Hers Climbs 6% Despite Five States Joining FTC Suit; Eli Lilly Dips, Novo Nordisk Holds Steady11 Nov
  • Hims & Hers Week in Review: Q3 Miss, Weak Q4 Outlook, Huberman Joins Board11 Nov
  • A $400 Billion Healthcare Opportunity: Telehealth Companies Positioned to Capitalize on a Massive Industry Shift11 Nov
  • HIMS Q3 Earnings Call Highlights Marketing Reset and Margin Pressure10 Nov
  • Hims & Hers Health: Don't Nitpick Quarterly Results10 Nov
  • Weight-Loss Reset Dents Hims & Hers Outlook, But Analyst Sees Opportunity10 Nov
  • Hims & Hers Drops 18% as Q3 Loss and Profit Outlook Cut Disappoint; Novo Nordisk Slides 2%, Eli Lilly Holds Steady10 Nov
  • 4 Post-Earnings Losers Drawing Unusual Options Volume10 Nov
  • Hims & Hers Celebrated Its Eli Lilly Deal, Then Lost a Quarter of Its Value in a Week10 Nov
  • HIMS Earnings Stumble on Double Miss, Guidance Becomes New Focus10 Nov
  • Hims & Hers: Why I'm Not Buying Back Yet (Rating Downgrade)10 Nov
  • Hims & Hers Stock Feels a Pinch Tuesday: What's Happening?10 Nov
  • Hims & Hers Just Warned Investors for the Third Time This Year. CEO Andrew Dudum Calls the Subscriber Losses a Trade He'll Make ‘Every Time'10 Nov

Mentions in Filings

  • … ecutive, particularly at technology companies. Other Public Company Boards: Mr. Amoo-Gottfried has served as a director of Vital Farms, Inc., a company that offers a range of ethically produced foods, since January 2021, and as a director of <strong>Hims & Hers Health, Inc.</strong>, a modern health and wellness company, since June 2026. Private Company / Non-Profit Boards: Mr. Amoo-Gottfried has served on the Board of Trustees of Macalester College since 2021.
    Stitch Fix, Inc.Hims & Hers Health, Inc.·DEF 14A - Definitive proxy statement·Q1 27·3 Nov
  • … this Summary Prospectus. **GraniteShares YIELDBOOST HIMS ETF – Summary** **Investment Objective** The Fund’s primary investment objective is to achieve 2 times (200%) the income generated from selling options on <strong>Hims & Hers Health</strong>, Inc.’s common stock (NYSE: HIMS) (the “Underlying Stock”) by selling options on leveraged exchange-traded funds designed to deliver 2 times (200%) the daily performance of the Underlying Stock (the “Underlying Leve …
    GraniteShares ETF TrustHims & Hers Health, Inc.·497K - Form 497K - Summary prospectus·28 Oct·28 Oct
  • … and wellness needs. Its platform includes access to a provider network, a clinically focused electronic medical record system, digital prescriptions, cloud pharmacy fulfillment, and personalization capabilities. <strong>Hims & Hers Health, Inc.</strong> is registered under the Securities Exchange Act of 1934, as amended (the “Exchange Act”). Information provided to or filed with the Securities and Exchange Commission by Hims & Hers Health, Inc. pursuant to the E …
    GraniteShares ETF TrustHims & Hers Health, Inc.·497 - Form 497 - Definitive materials (investment companies)·28 Oct·28 Oct
  • … 4,204 | 29.30 | 1,588,177.20 | | | | SPROUTS FARMERS MARKET INC | 24,277 | 82.68 | 2,007,222.36 | | | | TARGET CORP | 14,093 | 155.51 | 2,191,602.43 | | | | HCA HEALTHCARE INC | 4,471 | 411.74 | 1,840,889.54 | | | | <strong>HIMS & HERS HEALTH</strong> INC | 145,619 | 28.77 | 4,189,458.63 | | | | UNITEDHEALTH GROUP INC | 7,209 | 399.06 | 2,876,823.54 | | | | ELI LILLY & CO | 1,498 | 1,209.00 | 1,811,082.00 | | | | PFIZER INC | 111,105 | 26.80 | 2,977,614.00 | | | …
    三菱UFJアセットマネジメント株式会社Hims & Hers Health, Inc.·Annual Report - Annual Securities Report (2025.08.15-2026.08.14)·13 Nov·12 Nov
  • … 4,204 | 29.30 | 1,588,177.20 | | | | SPROUTS FARMERS MARKET INC | 24,277 | 82.68 | 2,007,222.36 | | | | TARGET CORP | 14,093 | 155.51 | 2,191,602.43 | | | | HCA HEALTHCARE INC | 4,471 | 411.74 | 1,840,889.54 | | | | <strong>HIMS & HERS HEALTH</strong> INC | 145,619 | 28.77 | 4,189,458.63 | | | | UNITEDHEALTH GROUP INC | 7,209 | 399.06 | 2,876,823.54 | | | | ELI LILLY & CO | 1,498 | 1,209.00 | 1,811,082.00 | | | | PFIZER INC | 111,105 | 26.80 | 2,977,614.00 | | | …
    三菱UFJアセットマネジメント株式会社Hims & Hers Health, Inc.·Prospectus - Securities registration statement·13 Nov·12 Nov
  • … 4,204 | 29.30 | 1,588,177.20 | | | | SPROUTS FARMERS MARKET INC | 24,277 | 82.68 | 2,007,222.36 | | | | TARGET CORP | 14,093 | 155.51 | 2,191,602.43 | | | | HCA HEALTHCARE INC | 4,471 | 411.74 | 1,840,889.54 | | | | <strong>HIMS & HERS HEALTH</strong> INC | 145,619 | 28.77 | 4,189,458.63 | | | | UNITEDHEALTH GROUP INC | 7,209 | 399.06 | 2,876,823.54 | | | | ELI LILLY & CO | 1,498 | 1,209.00 | 1,811,082.00 | | | | PFIZER INC | 111,105 | 26.80 | 2,977,614.00 | | | …
    三菱UFJアセットマネジメント株式会社Hims & Hers Health, Inc.·Prospectus - Securities registration statement·13 Nov·12 Nov

Key Stats

Trading

Px/Chg 1D$29.00 / -1.02%
Avg Volume30.89M
Beta2.53
Mkt Cap6.47B
FD Mkt Cap6.56B

Float

Shrs Out/Float223.08M / 208.82M
Short Float0.29%
Days to Cover3.23
Stock Repurchased$0.00

Current Valuation

EV7.38B
EV/EBITDA308.40
EV/Sales3.11
P/B14.50
P/S2.73
FCF Yield0.82%
ROE-20.65%
ROA-4.06%
Current Ratio1.69

Estimates

P/E-488.80
Est P/E0.00
Est EPS0.03
Est PEG0.00

Valuation

Metric5Yr AvgMay '23May '24May '25May '26Oct '26
PRICE-BASED RATIOS
Price / Earnings34.74-37.49-100.1169.94311.58-70.23
Price / Sales6.874.672.705.9710.3910.64
Price / Book Value11.927.906.8518.4911.8714.50
Price / Free Cash Flow1,592.42-72.9050.1644.447,818.38121.99
ENTERPRISE VALUE METRICS
Enterprise Value5,597.42,420.92,270.58,605.47,310.97,379.1
Enterprise Value / Sales7.404.592.605.8311.8312.13
Enterprise Value / EBITDA12.68-39.54-113.88108.94200.60-92.70
Enterprise Value / EBIT70.47-35.24-77.09139.01398.35-72.66

Financials

Full Financials
Millions USD5Yr CAGR (%)Dec '21Dec '22Dec '23Dec '24Dec '25
INCOME STATEMENT
Revenue71.4%271.9526.9872.01,476.52,347.6
Gross Income70.6%204.5408.7714.91,173.11,733.4
EBITDA—-111.0-61.2-19.979.0178.4
EBIT—-115.0-68.7-29.561.9123.9
Net Income—-107.7-65.7-23.5126.0128.4
EPS (Diluted)—-0.58-0.32-0.110.530.51
BALANCE SHEET
Cash & ST Inv23.6%247.3179.6221.0300.3577.5
Total Assets50.4%420.6366.3441.2707.52,154.7
Total Liabilities108.2%86.054.697.2230.81,613.8
Total Shareholder Equity12.8%334.6311.7344.0476.7540.9
CASH FLOW
Net Operating Cash Flow—-34.4-26.573.5251.1300.0
Cap Ex159.2%-5.0-7.2-26.5-52.8-226.0
Free Cash Flow—-39.4-33.847.0198.374.0

Enterprise Value Bridge

Millions USD13 Nov '26
Price (As of 13 Nov '26)19.74
Basic Shares223.08
Market Cap4,402.7
Diluted Shares231.75
Fully Diluted Shares Outstanding231.75
Fully Diluted Market Cap4,573.7
+Consolidated Debt1,546.2
−In-the-Money Convertible Debt—
+Capital Leases169.4
+Operating Leases—
−Cash & Equivalents-609.8
−Short-term Investments-231.2
+Total Preferred-
−In-the-Money Convertible Preferred—
−Investments in Unconsolidated Subs—
+Non-Controlling Interest-
+Pension Liabilities—
Enterprise Value5,339.1

Segment data

Revenue

by Geography

  • United States94%
  • Non-us6%

Related companies

HCA Healthcare, Inc.

HCA US

Tenet Healthcare Corp

THC US

Universal Health Services Inc

UHS US

Surgery Partners, Inc.

SGRY US

Teladoc Health, Inc.

TDOC US

Community Health Systems Inc

CYH US

Auna S.a.

AUNA US

PHYHEALTH Corp

OSCI US

Basel Medical Group Ltd

BMGL US

Rennova Health, Inc.

RNVA US

Cardiff Lexington Corp

CDIX US